These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

160 related articles for article (PubMed ID: 1968754)

  • 1. Effect of formoterol, a long-lasting beta 2-adrenoceptor agonist, against methacholine-induced bronchoconstriction.
    Nix A; Nichol GM; Robson A; Barnes PJ; Chung KF
    Br J Clin Pharmacol; 1990 Mar; 29(3):321-4. PubMed ID: 1968754
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Effects of treatment with formoterol on bronchoprotection against methacholine.
    Lipworth B; Tan S; Devlin M; Aiken T; Baker R; Hendrick D
    Am J Med; 1998 May; 104(5):431-8. PubMed ID: 9626025
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Formoterol, a new long-acting selective beta 2-adrenergic receptor agonist: double-blind comparison with salbutamol and placebo in children with asthma.
    Becker AB; Simons FE
    J Allergy Clin Immunol; 1989 Dec; 84(6 Pt 1):891-5. PubMed ID: 2574732
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Regular formoterol treatment in mild asthma. Effect on bronchial responsiveness during and after treatment.
    Yates DH; Sussman HS; Shaw MJ; Barnes PJ; Chung KF
    Am J Respir Crit Care Med; 1995 Oct; 152(4 Pt 1):1170-4. PubMed ID: 7551366
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Decreased bronchodilating effect of salbutamol in relieving methacholine induced moderate to severe bronchoconstriction during high dose treatment with long acting beta2 agonists.
    van der Woude HJ; Winter TH; Aalbers R
    Thorax; 2001 Jul; 56(7):529-35. PubMed ID: 11413351
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Acute relief of exercise-induced bronchoconstriction by inhaled formoterol in children with persistent asthma.
    Hermansen MN; Nielsen KG; Buchvald F; Jespersen JJ; Bengtsson T; Bisgaard H
    Chest; 2006 May; 129(5):1203-9. PubMed ID: 16685010
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Prolonged protection against methacholine-induced bronchoconstriction by the inhaled beta 2-agonist formoterol.
    Ramsdale EH; Otis J; Kline PA; Gontovnick LS; Hargreave FE; O'Byrne PM
    Am Rev Respir Dis; 1991 May; 143(5 Pt 1):998-1001. PubMed ID: 1673830
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of the long acting beta agonist formoterol on asthma control in asthmatic patients using inhaled corticosteroids. The Netherlands and Canadian Formoterol Study Investigators.
    van der Molen T; Postma DS; Turner MO; Jong BM; Malo JL; Chapman K; Grossman R; de Graaff CS; Riemersma RA; Sears MR
    Thorax; 1997 Jun; 52(6):535-9. PubMed ID: 9227720
    [TBL] [Abstract][Full Text] [Related]  

  • 9. In vivo effect of albuterol on methacholine-contracted bronchi in conjunction with salmeterol and formoterol.
    Aziz I; Lipworth BJ
    J Allergy Clin Immunol; 1999 May; 103(5 Pt 1):816-22. PubMed ID: 10329815
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Is the increase in bronchial responsiveness or FEV1 shortly after cessation of beta2-agonists reflecting a real deterioration of the disease in allergic asthmatic patients? A comparison between short-acting and long-acting beta2-agonists.
    van Schayck CP; Cloosterman SG; Bijl-Hofland ID; van den Hoogen H; Folgering HT; van Weel C
    Respir Med; 2002 Mar; 96(3):155-62. PubMed ID: 11908511
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Preventive effects of inhaled formoterol and salbutamol on histamine-induced bronchoconstriction--a placebo-controlled study.
    Sovijärvi AR; Reinikainen K; Freudenthal Y; Andersson P; Riska H
    Respiration; 1992; 59(5):279-82. PubMed ID: 1488561
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Formoterol, a new long-acting selective beta 2-agonist, decreases airway responsiveness in children with asthma.
    Becker AB; Simons FE
    Lung; 1990; 168 Suppl():99-102. PubMed ID: 1974689
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Budesonide/formoterol in a single inhaler rapidly relieves methacholine-induced moderate-to-severe bronchoconstriction.
    van der Woude HJ; Boorsma M; Bergqvist PB; Winter TH; Aalbers R
    Pulm Pharmacol Ther; 2004; 17(2):89-95. PubMed ID: 15123230
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Rebound airway obstruction and responsiveness after cessation of terbutaline: effects of budesonide.
    de Jong JW; van der Mark TW; Koëter GH; Postma DS
    Am J Respir Crit Care Med; 1996 Jan; 153(1):70-5. PubMed ID: 8542165
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Dose-related effects of formoterol on airway responsiveness to adenosine 5'-monophosphate and histamine.
    Ketchell RI; Jensen MW; Spina D; O'Connor BJ
    Eur Respir J; 2002 Apr; 19(4):611-6. PubMed ID: 11998988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Comparison of formoterol and terbutaline for as-needed treatment of asthma: a randomised trial.
    Tattersfield AE; Löfdahl CG; Postma DS; Eivindson A; Schreurs AG; Rasidakis A; Ekström T
    Lancet; 2001 Jan; 357(9252):257-61. PubMed ID: 11214127
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Formoterol, a new inhaled beta-2 adrenergic agonist, has a longer blocking effect than albuterol on hyperventilation-induced bronchoconstriction.
    Malo JL; Cartier A; Trudeau C; Ghezzo H; Gontovnick L
    Am Rev Respir Dis; 1990 Nov; 142(5):1147-52. PubMed ID: 1978619
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protection against cold air and exercise-induced bronchoconstriction while on regular treatment with Oxis.
    Vilsvik J; Ankerst J; Palmqvist M; Persson G; Schaanning J; Schwabe G; Johansson A
    Respir Med; 2001 Jun; 95(6):484-90. PubMed ID: 11421506
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Speeds of action of single doses of formoterol and salbutamol compared with placebo in reversing methacholine-induced bronchoconstriction.
    Beach JR; Bromly CL; Avery AJ; Reid RW; Walters EH; Hendrick DJ
    Pulm Pharmacol; 1996 Aug; 9(4):245-9. PubMed ID: 9160413
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential masking effect on dyspnoea perception by short- and long-acting beta2-agonists in asthma.
    van Schayck CP; Bijl-Hofland ID; Cloosterman SG; Folgering HT; van der Elshout FJ; Van Weel C
    Eur Respir J; 2002 Feb; 19(2):240-5. PubMed ID: 11871364
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.